Mobile Gamma Cameras Market Set to Hit USD 79.2 Million by 2033: Key Trends and Drivers

The global mobile gamma cameras market is experiencing significant growth, driven by technological advancements in medical imaging and a rising prevalence of chronic diseases. Valued at USD 57.8 million in 2024, the market is projected to reach USD 79.2 million by 2033, exhibiting a CAGR of 3.39% from 2025 to 2033. The increasing demand for portable diagnostic devices, especially in oncology and cardiology, along with supportive government healthcare initiatives, are key factors propelling this growth. North America currently leads the market, holding over 35.0% share in 2024, attributed to its advanced healthcare infrastructure and rapid adoption of modern medical technologies. 

STUDY ASSUMPTION YEARS

• Base Year: 2024
• Historical Years: 2019-2024
• Forecast Years: 2025-2033

MOBILE GAMMA CAMERAS MARKET KEY TAKEAWAYS

• Market Size & Growth: The market was valued at USD 57.8 million in 2024 and is expected to reach USD 79.2 million by 2033, growing at a CAGR of 3.39% during 2025-2033.
• Regional Dominance: North America holds the largest market share, over 35.0% in 2024, due to advanced healthcare infrastructure and high adoption of modern medical technologies.
• Product Segmentation: Single-head mobile gamma cameras dominate the product segment, accounting for 62.9% market share in 2024, owing to their cost-effectiveness and versatility.
• Application Insights: Thyroid scanning leads the application segment, driven by the increasing prevalence of thyroid disorders and the need for accurate diagnostic imaging.
• End User Analysis: Hospitals are the primary end users, holding 41.3% market share in 2024, due to their extensive infrastructure and large patient volume.
• Technological Advancements: Integration of solid-state detectors, AI-powered imaging software, and improved energy resolution are enhancing diagnostic efficiency and accuracy.
• Portability Trend: The shift towards portable and point-of-care diagnostic solutions is increasing the adoption of mobile gamma cameras in various clinical settings.

MARKET GROWTH FACTORS

1. Technological Advancements in Medical Imaging

The evolution of medical imaging technology has significantly impacted the mobile gamma cameras market. Modern gamma cameras now incorporate solid-state detectors, high-energy collimators, and AI-powered imaging software, enhancing image quality and diagnostic accuracy. These advancements allow for faster scanning and real-time imaging, which are crucial in emergency and intraoperative settings. The integration of digital systems and improved spatial resolution further support the growing demand for precise and efficient diagnostic tools. As healthcare providers seek to improve patient outcomes and operational efficiency, the adoption of advanced mobile gamma cameras is expected to rise.

2. Rising Prevalence of Chronic Diseases

The increasing incidence of chronic diseases, such as cancer and cardiovascular disorders, is a major driver of the mobile gamma cameras market. According to the World Health Organization, noncommunicable diseases account for 74% of all global deaths. Mobile gamma cameras play a vital role in the early detection and monitoring of these conditions, offering flexibility and accessibility in various healthcare settings. Their portability allows for use in outpatient facilities, emergency departments, and rural areas, ensuring timely diagnosis and treatment. As the global burden of chronic diseases continues to rise, the demand for mobile gamma cameras is expected to grow correspondingly.

3. Shift Towards Portable and Point-of-Care Solutions

The healthcare industry's move towards decentralized and patient-centric care models has increased the demand for portable diagnostic devices. Mobile gamma cameras offer the advantage of bedside imaging, reducing the need for patient transport and enabling immediate diagnostic decisions. This is particularly beneficial in critical care units and for patients with mobility constraints. The ability to perform imaging in various clinical settings, including outpatient clinics and rural healthcare centers, aligns with the trend of improving healthcare accessibility and efficiency. As healthcare systems aim to reduce costs and enhance patient care, the adoption of mobile gamma cameras is anticipated to expand. 

Request for a sample copy of this report: 

https://www.imarcgroup.com/mobile-gamma-cameras-market/requestsample

MARKET SEGMENTATION

By Product:

• Single-head Mobile Gamma Cameras: Dominating the market with 62.9% share in 2024, these cameras are cost-effective and versatile, suitable for various clinical applications.
• Dual-head Mobile Gamma Cameras: Offer enhanced imaging capabilities, providing better resolution and faster scanning times for complex diagnostic procedures.
• Triple-head Mobile Gamma Cameras: Provide superior image quality and are used in advanced diagnostic applications requiring high precision.
• Handheld Mobile Gamma Camera: Compact and portable, ideal for intraoperative imaging and point-of-care diagnostics in diverse clinical settings.

By Application:

• Cardiac Imaging: Utilized for assessing myocardial perfusion and detecting coronary artery diseases, aiding in timely intervention.
• Breast Imaging: Assists in the detection and localization of breast tumors, especially in dense breast tissues where mammography may be less effective.
• Thyroid Scanning: Essential for diagnosing thyroid disorders, including hyperthyroidism and thyroid nodules, by evaluating gland function and structure.
• Kidney Scanning: Helps in assessing renal function and detecting abnormalities such as obstructions or infections.
• Intraoperative Imaging: Provides real-time imaging during surgical procedures, enhancing precision and outcomes.
• Brain Imaging: Used in the evaluation of neurological conditions, including epilepsy and brain tumors, through functional imaging.
• Others: Includes applications in bone scanning and infection imaging, contributing to comprehensive diagnostic capabilities.

By End User:

• Hospitals: Leading end users with 41.3% market share in 2024, due to extensive infrastructure and diverse diagnostic needs.
• Ambulatory Surgical Centers: Adopt mobile gamma cameras for their portability and efficiency in outpatient surgical procedures.
• Research Centers: Utilize these devices for clinical studies and the development of new diagnostic techniques.
• Imaging Centers and Clinics: Implement mobile gamma cameras to offer specialized imaging services with flexibility and reduced operational costs.

By Region:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

REGIONAL INSIGHTS

North America leads the mobile gamma cameras market, holding over 35.0% share in 2024. The region's advanced healthcare infrastructure, high prevalence of chronic diseases, and rapid adoption of modern medical technologies contribute to this dominance. Supportive government healthcare initiatives and the presence of key market players further bolster market growth in this region.

RECENT DEVELOPMENTS & NEWS

• October 2024: Serac Imaging Systems announced promising clinical findings for Seracam®, a portable gamma-optical camera, in sentinel lymph node imaging for breast cancer. The device offers visual imaging alongside gamma radiation detection, enhancing anatomical context and precision.
• August 2024: Royal Shrewsbury Hospital introduced a new gamma camera as part of a £3.6 million investment to improve cancer and acute condition diagnostics. The advanced camera enhances image quality, reduces waiting times, and supports expanded imaging services.
• February 2024: M3D, Inc. received investment from Michigan Rise Pre-Seed Fund III to advance its gamma radiation detection cameras. The funding will aid in finalizing design and conducting field testing, with a commercial release expected by mid-2024. 

KEY PLAYERS

CMR Naviscan Corporation, Crystal Photonics GmbH, DDD-Diagnostic A/S, Digirad Corporation, Dilon Medical Technologies Inc., GAEDE Medizinsysteme GmbH, Mediso Ltd., MiE GmbH, Oncovision Inc., Siemens AG and Spectrum Dynamics Medical (Biosensors International Group Ltd.)

Ask Analyst for Customization: 

https://www.imarcgroup.com/request?type=report&id=5895&flag=C

If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provides a comprehensive suite of market entry and expansion services. IMARC offerings include a thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape, and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145